{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:11:42Z","timestamp":1791335502853,"version":"4.3.1"},"reference-count":23,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2018,3,12]]},"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To evaluate the clinical characteristics and treatment outcomes of natural killer\/T-cell lymphoma (NKTL) involving the ocular adnexa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective, comparative, observational case series. A total of 350 patients with NKTL, including 27 patients with NKTL involving the ocular adnexa from 1999 to 2016. The patients were grouped into two groups: group 1 comprised patients presenting with ophthalmic symptoms, and\u00a0group 2 comprised patients presenting with symptoms from other organs but subsequently developed ophthalmic involvement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Group 1 comprised 12 patients (44.4%) and group 2 comprised 15 (55.6%). Mean duration of symptoms in group 1 was 1.8\u00b11.2 months, while the time from diagnosis of NKTL to development of ophthalmic symptoms in group 2 was 45.3\u00b165.6 months. Periorbital swelling was the most common presenting symptom in both groups (83.3% in group 1 and 73.3% in group 2). Symptoms mimicking cellulitis and pseudotumor were present in 50.0% and 16.7% of cases, respectively. The 5-year\u00a0overall survival rate was 18.5% in group 1 and 26.4% in group\u00a02, while the 5-year\u00a0progression-free survival rate was 0% and 13.3%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our series is to our knowledge the largest cohort study on NKTL reported to date and demonstrates that ocular adnexal NKTL is a rare but seriously fatal disease. It is characterised by acute inflammatory signs as present in as many as two-thirds of our patients in this series. It should be considered as a differential diagnosis in patients presenting with rapidly progressing proptosis and diagnosed promptly for optimal management.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-311704","type":"journal-article","created":{"date-parts":[[2018,4,29]],"date-time":"2018-04-29T16:25:35Z","timestamp":1525019135000},"page":"269-273","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical characteristics and treatment outcomes of natural killer\/T-cell lymphoma involving the ocular adnexa"],"prefix":"10.1136","volume":"103","author":[{"given":"Ga-In","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Duck","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Ming","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonae","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung In","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,4,29]]},"reference":[{"key":"2024100707200660000_103.2.269.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)98024-1"},{"key":"2024100707200660000_103.2.269.2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-008-9220-8"},{"key":"2024100707200660000_103.2.269.3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/08820538.2016.1228405","article-title":"Natural killer T-Cell lymphoma of the orbit: an evidence-based approach","volume":"32","author":"Jim\u00e9nez-P\u00e9rez","year":"2017","journal-title":"Semin Ophthalmol"},{"key":"2024100707200660000_103.2.269.4","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.181"},{"key":"2024100707200660000_103.2.269.5","doi-asserted-by":"publisher","DOI":"10.1002\/hon.847"},{"key":"2024100707200660000_103.2.269.6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000099297","article-title":"Primary ocular natural killer\/T-cell lymphomas: clinicopathologic features and diagnosis","volume":"221","author":"Yang","year":"2007","journal-title":"Ophthalmologica"},{"key":"2024100707200660000_103.2.269.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01520-9"},{"key":"2024100707200660000_103.2.269.8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1053\/hupa.2003.33","article-title":"Nasal-type NK\/T cell lymphoma of the orbit with distant metastases","volume":"34","author":"Kuwabara","year":"2003","journal-title":"Hum Pathol"},{"key":"2024100707200660000_103.2.269.9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.oftal.2013.10.006","article-title":"Orbital involvement by non-Hodgkin lymphoma NK T cells","volume":"89","author":"Herv\u00e1s-Ontiveros","year":"2014","journal-title":"Arch Soc Esp Oftalmol"},{"key":"2024100707200660000_103.2.269.10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/01676830.2011.605506","article-title":"Orbital involvement in extranodal natural killer T cell lymphoma: an atypical case presentation and review of the literature","volume":"31","author":"Ely","year":"2012","journal-title":"Orbit"},{"key":"2024100707200660000_103.2.269.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.09.036"},{"key":"2024100707200660000_103.2.269.12","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213350.49767.46"},{"key":"2024100707200660000_103.2.269.13","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10332"},{"key":"2024100707200660000_103.2.269.14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.12659\/AJCR.899922","article-title":"Nasal type extranodal Natural killer\/T (NK\/T) cell lymphoma presenting as periorbital cellulitis: a case report","volume":"17","author":"Al Shawabkeh","year":"2016","journal-title":"Am J Case Rep"},{"key":"2024100707200660000_103.2.269.15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/SCS.0000000000000677","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type, of the orbit mimicking recurrent orbital cellulitis","volume":"25","author":"Kim","year":"2014","journal-title":"J Craniofac Surg"},{"key":"2024100707200660000_103.2.269.16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/01676830.2012.736603","article-title":"CD56 negative extranodal NK\/T-cell lymphoma of the orbit mimicking orbital cellulitis","volume":"32","author":"Pine","year":"2013","journal-title":"Orbit"},{"key":"2024100707200660000_103.2.269.17","doi-asserted-by":"publisher","DOI":"10.1080\/01676830490916064"},{"key":"2024100707200660000_103.2.269.18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2403"},{"key":"2024100707200660000_103.2.269.19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/01676830.2014.902478","article-title":"Series of extranodal natural killer\/T-cell lymphoma, nasal type, with periorbital involvement","volume":"33","author":"Termote","year":"2014","journal-title":"Orbit"},{"key":"2024100707200660000_103.2.269.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-185256"},{"key":"2024100707200660000_103.2.269.21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/10245330400026162","article-title":"NK-cell neoplasms in Japan","volume":"10","author":"Oshimi","year":"2005","journal-title":"Hematology"},{"key":"2024100707200660000_103.2.269.22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0609.2012.01796.x","article-title":"Clinical features and prognostic model for extranasal NK\/T-cell lymphoma","volume":"89","author":"Jo","year":"2012","journal-title":"Eur J Haematol"},{"key":"2024100707200660000_103.2.269.23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.1384"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-311704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T14:21:37Z","timestamp":1728310897000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-311704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,29]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,1,22]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/bjophthalmol-2017-311704"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311704","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,29]]}}}